The impact of MYB amplification in ACC is probably limited, as copy number gains of MYB has been reported only incidentally [16, 55] and predominantly in cases already harboring “conventional” MYB-NFIB fusion [16]. The gene discussed is MYB; the disease is adrenal cortex carcinoma.